State Street’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$445K Buy
153,451
+4,540
+3% +$13.2K ﹤0.01% 3640
2025
Q1
$107K Hold
148,911
﹤0.01% 3962
2024
Q4
$153K Buy
148,911
+18,400
+14% +$19K ﹤0.01% 3909
2024
Q3
$175K Hold
130,511
﹤0.01% 3850
2024
Q2
$170K Hold
130,511
﹤0.01% 3866
2024
Q1
$224K Hold
130,511
﹤0.01% 3850
2023
Q4
$192K Hold
130,511
﹤0.01% 3910
2023
Q3
$158K Buy
130,511
+19,800
+18% +$24K ﹤0.01% 3994
2023
Q2
$161K Hold
110,711
﹤0.01% 4069
2023
Q1
$161K Hold
110,711
﹤0.01% 4148
2022
Q4
$192K Buy
110,711
+19,400
+21% +$33.6K ﹤0.01% 4117
2022
Q3
$183K Sell
91,311
-9,073
-9% -$18.2K ﹤0.01% 4188
2022
Q2
$74K Sell
100,384
-396,801
-80% -$293K ﹤0.01% 4630
2022
Q1
$4.33M Sell
497,185
-346,770
-41% -$3.02M ﹤0.01% 3254
2021
Q4
$13.5M Buy
843,955
+41,264
+5% +$661K ﹤0.01% 2734
2021
Q3
$14.8M Sell
802,691
-8,047
-1% -$148K ﹤0.01% 2665
2021
Q2
$11.3M Sell
810,738
-545,805
-40% -$7.62M ﹤0.01% 2847
2021
Q1
$20M Buy
1,356,543
+1,017,712
+300% +$15M ﹤0.01% 2369
2020
Q4
$6.57M Buy
338,831
+53,239
+19% +$1.03M ﹤0.01% 2827
2020
Q3
$3.19M Sell
285,592
-2,982
-1% -$33.3K ﹤0.01% 3010
2020
Q2
$3.9M Buy
288,574
+10,131
+4% +$137K ﹤0.01% 2886
2020
Q1
$2.25M Buy
278,443
+69,852
+33% +$564K ﹤0.01% 3010
2019
Q4
$2.01M Buy
208,591
+11,365
+6% +$109K ﹤0.01% 3245
2019
Q3
$2.09M Buy
197,226
+27,695
+16% +$294K ﹤0.01% 3203
2019
Q2
$1.95M Buy
169,531
+60,396
+55% +$695K ﹤0.01% 3250
2019
Q1
$1.4M Sell
109,135
-42,958
-28% -$550K ﹤0.01% 3269
2018
Q4
$935K Buy
152,093
+24,168
+19% +$149K ﹤0.01% 3341
2018
Q3
$1.34M Buy
127,925
+66,727
+109% +$701K ﹤0.01% 3356
2018
Q2
$898K Buy
61,198
+29,525
+93% +$433K ﹤0.01% 3414
2018
Q1
$451K Buy
+31,673
New +$451K ﹤0.01% 3447